BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19470575)

  • 1. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study.
    Okuma T; Matsuoka T; Yamamoto A; Hamamoto S; Nakamura K; Inoue Y
    Br J Radiol; 2009 Dec; 82(984):989-94. PubMed ID: 19470575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Hamamoto S; Toyoshima M; Nakamura K; Miki Y
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):787-93. PubMed ID: 19967367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of diffusion-weighted magnetic resonance imaging in evaluation of early therapeutic response after CT-guided microwave ablation of inoperable lung neoplasms.
    Vogl TJ; Emara EH; Elhawash E; Naguib NNN; Aboelezz MO; Abdelrahman HM; Saber S; Nour-Eldin NA
    Eur Radiol; 2022 May; 32(5):3288-3296. PubMed ID: 34797384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cone-Beam Computed Tomography (CBCT) Versus CT in Lung Ablation Procedure: Which is Faster?
    Cazzato RL; Battistuzzi JB; Catena V; Grasso RF; Zobel BB; Schena E; Buy X; Palussiere J
    Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1231-6. PubMed ID: 25787903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic radiofrequency under CT-fluoroscopy guidance.
    Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C
    Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
    Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
    Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
    Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
    Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
    Barat M; Fohlen A; Cassinotto C; Jannot AS; Dautry R; Pelage JP; Boudiaf M; Pocard M; Eveno C; Taouli B; Soyer P; Dohan A
    J Magn Reson Imaging; 2017 Jun; 45(6):1648-1658. PubMed ID: 27766709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study.
    Shao GL; Zheng JP; Guo LW; Chen YT; Zeng H; Yao Z
    Medicine (Baltimore); 2017 Jan; 96(3):e5518. PubMed ID: 28099329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
    Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
    AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Inoue K; Nakamura K; Inoue Y
    J Vasc Interv Radiol; 2007 Mar; 18(3):399-404. PubMed ID: 17377186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
    Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
    Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation therapy of non-colorectal cancer lung metastases: retrospective analysis of tumour response post-laser-induced interstitial thermotherapy (LITT), radiofrequency ablation (RFA) and microwave ablation (MWA).
    Nour-Eldin NA; Exner S; Al-Subhi M; Naguib NNN; Kaltenbach B; Roman A; Vogl TJ
    Int J Hyperthermia; 2017 Nov; 33(7):820-829. PubMed ID: 28540791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion weighted MRI of osteoid osteomas: Higher ADC values after radiofrequency ablation.
    Rheinheimer S; Görlach J; Figiel J; Mahnken AH
    Eur J Radiol; 2016 Jul; 85(7):1284-8. PubMed ID: 27235875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour characteristics and therapeutic results after percutaneous radiofrequency ablation of secondary lung neoplasms.
    Dequanter D; Lothaire P
    Clin Transl Oncol; 2009 Jun; 11(6):393-5. PubMed ID: 19531455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-MicroPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits.
    Ohira T; Okuma T; Matsuoka T; Wada Y; Nakamura K; Watanabe Y; Inoue Y
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):114-20. PubMed ID: 18696151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography-guided re-radiofrequency ablation for unresectable lung tumor with local progression previously treated with the same procedure.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Nakamura K; Inoue Y
    Radiat Med; 2008 Nov; 26(9):519-25. PubMed ID: 19030959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
    Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of computed tomography-guided radiofrequency ablation of renal cancer: a 14-year single institution experience in 203 patients.
    Iannuccilli JD; Dupuy DE; Beland MD; Machan JT; Golijanin DJ; Mayo-Smith WW
    Eur Radiol; 2016 Jun; 26(6):1656-64. PubMed ID: 26373755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.